Guangjiang Shi

1.4k total citations
14 papers, 956 citations indexed

About

Guangjiang Shi is a scholar working on Molecular Biology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guangjiang Shi has authored 14 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Reproductive Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guangjiang Shi's work include Sperm and Testicular Function (3 papers), Hormonal and reproductive studies (2 papers) and Polysaccharides and Plant Cell Walls (2 papers). Guangjiang Shi is often cited by papers focused on Sperm and Testicular Function (3 papers), Hormonal and reproductive studies (2 papers) and Polysaccharides and Plant Cell Walls (2 papers). Guangjiang Shi collaborates with scholars based in China, United States and Singapore. Guangjiang Shi's co-authors include Jianqiang Yu, Dandan Huang, Yaping Jiang, Yong Yang, Chao Yao, Hongxi Wu, Zhen Chen, Yu‐Xiang Li, Jing Wu and Xinghua Gao and has published in prestigious journals such as Hepatology, Cancer Research and Biochemical Pharmacology.

In The Last Decade

Guangjiang Shi

14 papers receiving 942 citations

Peers

Guangjiang Shi
Guangjiang Shi
Citations per year, relative to Guangjiang Shi Guangjiang Shi (= 1×) peers Yu‐Xiang Li

Countries citing papers authored by Guangjiang Shi

Since Specialization
Citations

This map shows the geographic impact of Guangjiang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangjiang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangjiang Shi more than expected).

Fields of papers citing papers by Guangjiang Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangjiang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangjiang Shi. The network helps show where Guangjiang Shi may publish in the future.

Co-authorship network of co-authors of Guangjiang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Guangjiang Shi. A scholar is included among the top collaborators of Guangjiang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangjiang Shi. Guangjiang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Sun, Peng, Jiaxi Ru, Xiaoyan Li, et al.. (2024). Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2. Journal of Nanobiotechnology. 22(1). 11–11. 4 indexed citations
3.
Li, Yan, Guangjiang Shi, Xiaobin Wang, et al.. (2022). A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer. Acta Pharmaceutica Sinica B. 12(11). 4165–4179. 8 indexed citations
5.
Shi, Guangjiang, Zixuan Zhang, Yan Li, et al.. (2021). Hepatic interferon regulatory factor 8 expression mediates liver ischemia/reperfusion injury in mice. Biochemical Pharmacology. 192. 114728–114728. 6 indexed citations
6.
Wu, Hongxi, Linjun You, Zhili Zhao, et al.. (2020). Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance. Cancer Research. 80(13). 2927–2939. 15 indexed citations
7.
Huang, Dandan, et al.. (2020). A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomedicine & Pharmacotherapy. 125. 109767–109767. 175 indexed citations
8.
Chen, Lei, et al.. (2019). Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention. Biomedicine & Pharmacotherapy. 112. 108585–108585. 116 indexed citations
9.
Shi, Guangjiang, Yan Li, Qiuhua Cao, et al.. (2018). In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomedicine & Pharmacotherapy. 109. 1085–1099. 231 indexed citations
10.
Shi, Guangjiang, Wenjin Zhang, Yaping Jiang, et al.. (2018). Involvement of growth factors in diabetes mellitus and its complications: A general review. Biomedicine & Pharmacotherapy. 101. 510–527. 105 indexed citations
11.
Shi, Guangjiang, Zhimei Li, Jie Zheng, et al.. (2017). Diabetes associated with male reproductive system damages: Onset of presentation, pathophysiological mechanisms and drug intervention. Biomedicine & Pharmacotherapy. 90. 562–574. 77 indexed citations
14.
Wang, Hongling, Yu‐Xiang Li, Jie Zheng, et al.. (2015). Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice. Inflammation. 38(6). 2269–2278. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026